Clinical Trial Update: REMS Retigabine Study

View source ↗

Summary

A REMS-related clinical trial update for retigabine (ezogabine) in epilepsy has completed. The study was sponsored by GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Potiga (ezogabine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Epilepsy | Status: COMPLETED